科拓生物(300858)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300858 科拓生物

已收盘 07-25 15:00:00

{"stockData":{"symbol":"300858","market":"SZ","secType":"STK","nameCN":"科拓生物","latestPrice":14.23,"timestamp":1721890995000,"preClose":14.08,"halted":0,"volume":907654,"delay":0,"floatShares":179000000,"shares":263000000,"eps":0.349,"marketStatus":"已收盘","marketStatusCode":5,"change":0.15,"latestTime":"07-25 15:00:00","open":13.92,"high":14.42,"low":13.92,"amount":12896700,"amplitude":0.0355,"askPrice":14.23,"askSize":13,"bidPrice":14.22,"bidSize":4,"shortable":0,"etf":0,"ttmEps":0.349,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721957400000},"adr":0,"adjPreClose":14.08,"symbolType":"stock","openAndCloseTimeList":[[1721871000000,1721878200000],[1721883600000,1721890800000]],"highLimit":15.49,"lowLimit":12.67,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":263495118,"pbRate":2.12,"roa":"--","roe":"1.06%","epsLYR":0.35,"committee":0.189394,"marketValue":3750000000,"floatMarketCap":2547000000,"peRate":40.773638,"changeRate":0.0107,"turnoverRate":0.0051,"status":0},"requestUrl":"/m/hq/s/300858","defaultTab":"news","newsList":[{"id":"2452187079","title":"科拓生物最新公告：近日共获得8项专利证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2452187079","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452187079?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:36","pubTimestamp":1721205377,"startTime":"0","endTime":"0","summary":"科拓生物公告，公司及全资子公司金华银河生物科技有限公司、内蒙古科拓生物有限公司于近期收到国家知识产权局颁发的8项专利证书，其中包括5项发明专利和3项实用新型专利。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071700033542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"gpt_icon":0},{"id":"2451791686","title":"科拓生物获得发明专利授权：“一种用于改善食品贮藏品质的后生元组合物”","url":"https://stock-news.laohu8.com/highlight/detail?id=2451791686","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451791686?lang=zh_cn&edition=full","pubTime":"2024-07-16 02:20","pubTimestamp":1721067620,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示科拓生物新获得一项发明专利授权，专利名为“一种用于改善食品贮藏品质的后生元组合物”，专利申请号为CN202311267407.6，授权日为2024年7月12日。今年以来科拓生物新获得专利授权2个，较去年同期增加了100%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071600002047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"gpt_icon":0},{"id":"2450817863","title":"科拓生物（300858）7月11日主力资金净买入133.80万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450817863","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450817863?lang=zh_cn&edition=full","pubTime":"2024-07-11 15:25","pubTimestamp":1720682720,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年7月11日收盘，科拓生物报收于14.8元，上涨0.2%，换手率0.55%，成交量9859.0手，成交额1469.88万元。科拓生物主营业务：从事复配食品添加剂、食用益生菌制品以及动植物微生态制剂研发、生产与销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071100024210.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"gpt_icon":0},{"id":"2446645673","title":"科拓生物：公司参与项目获2023年度国家科学技术进步奖二等奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2446645673","media":"中国财富通","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446645673?lang=zh_cn&edition=full","pubTime":"2024-06-26 19:46","pubTimestamp":1719402372,"startTime":"0","endTime":"0","summary":"中国财富通6月26日 - 科拓生物（300858）公告称，公司参与的《优良乳酸菌种质资源挖掘与产业化关键技术创制及应用》项目荣获2023年度国家科学技术进步奖二等奖。国家科学技术进步奖是科技领域最具权威性和影响力的奖项之一，此次获奖是对公司在益生菌行业研发能力及创新能力的充分肯定，体现了公司的技术进步和研发实力，有助于进一步提升公司产品的市场竞争力和公司的品牌影响力。未来，公司将继续以基础应用科学研究为基础，支撑新技术和新产品开发，助力行业高质量发展。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://irb.cfbond.com/api/v1/detail.html?newsid=Z47NPXDH6XE%3D","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300858","BK0226"],"gpt_icon":0},{"id":"2446356027","title":"科拓生物最新公告：参与项目获国家科学技术进步奖二等奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2446356027","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446356027?lang=zh_cn&edition=full","pubTime":"2024-06-26 16:35","pubTimestamp":1719390943,"startTime":"0","endTime":"0","summary":"科拓生物公告，公司参与的《优良乳酸菌种质资源挖掘与产业化关键技术创制及应用》项目荣获2023年度国家科学技术进步奖二等奖。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062600032512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"gpt_icon":0},{"id":"2446035847","title":"科拓生物(300858.SZ)：荣获国家科学技术进步奖二等奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2446035847","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446035847?lang=zh_cn&edition=full","pubTime":"2024-06-26 15:44","pubTimestamp":1719387864,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科拓生物(300858.SZ)公告，公司参与的《优良乳酸菌种质资源挖掘与产业化关键技术创制及应用》项目(“项目”)荣获2023年度国家科学技术进步奖二等奖。据悉，该项目攻克了乳酸菌代谢调控培养和细胞损伤靶向保护工程技术，突破了高活性乳酸菌产业化卡脖子难题、创制了菌株高效互作和精准配伍关键技术，打破了国外菌株、技术和产品的垄断。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1140721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0226","300858"],"gpt_icon":0},{"id":"2446816788","title":"科拓生物(300858.SZ)拟10股派1.5元 于7月3日除权除息","url":"https://stock-news.laohu8.com/highlight/detail?id=2446816788","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446816788?lang=zh_cn&edition=full","pubTime":"2024-06-25 18:47","pubTimestamp":1719312471,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科拓生物(300858.SZ)公告，公司2023年年度权益分派拟：向全体股东每10股派发现金股利人民币1.50元(含税)。除权除息日为：2024年7月3日。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1140241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300858","BK0226"],"gpt_icon":0},{"id":"2445470350","title":"6月24日科拓生物跌7.70%，鹏华新兴产业混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445470350","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445470350?lang=zh_cn&edition=full","pubTime":"2024-06-24 16:35","pubTimestamp":1719218139,"startTime":"0","endTime":"0","summary":"证券之星消息，6月24日科拓生物跌7.70%，收盘报14.62元，换手率1.26%，成交量2.26万手，成交额3369.92万元。重仓科拓生物的前十大公募基金请见下表：该股最近90天内共有4家机构给出评级，买入评级4家；过去90天内机构目标均价为17.67。根据2024基金Q1季报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为鹏华新兴产业混合。鹏华新兴产业混合目前规模为28.61亿元，最新净值2.512，较上一交易日上涨0.52%，近一年下跌16.96%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062400021212.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"gpt_icon":0},{"id":"2445738053","title":"科拓生物涨5.46%，东吴证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2445738053","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445738053?lang=zh_cn&edition=full","pubTime":"2024-06-21 16:20","pubTimestamp":1718958051,"startTime":"0","endTime":"0","summary":"今日科拓生物涨5.46%，收盘报15.84元。2024年4月25日，东吴证券研究员孙瑜,周韵发布了对科拓生物的研报《2023年年报&2024年一季报点评：益生菌业务表现亮眼，加速战略转型》，该研报对科拓生物给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为78.73%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为东吴证券的孙瑜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024062100032548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","300858"],"gpt_icon":0},{"id":"2435677186","title":"科拓生物(300858.SZ)授出260万股限制性股票 授予价为13元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2435677186","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435677186?lang=zh_cn&edition=full","pubTime":"2024-05-16 20:59","pubTimestamp":1715864393,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科拓生物(300858.SZ)公告，公司2024年限制性股票激励计划规定的限制性股票首次授予条件已经成就，确定2024年5月15日为首次授予日，向符合条件的17名激励对象授予260万股限制性股票，限制性股票授予价格13.00元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1122258.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0226","300858"],"gpt_icon":0},{"id":"2431883709","title":"科拓生物涨5.21%，东吴证券四日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2431883709","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431883709?lang=zh_cn&edition=full","pubTime":"2024-04-29 16:42","pubTimestamp":1714380179,"startTime":"0","endTime":"0","summary":"今日科拓生物涨5.21%，收盘报16.36元。2024年4月25日，东吴证券研究员孙瑜,周韵发布了对科拓生物的研报《2023年年报&2024年一季报点评：益生菌业务表现亮眼，加速战略转型》，该研报对科拓生物给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为78.73%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为东吴证券的孙瑜。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900017750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","601555"],"gpt_icon":0},{"id":"2430263455","title":"科拓生物（300858）2024年一季报简析：净利润减7.66%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2430263455","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430263455?lang=zh_cn&edition=full","pubTime":"2024-04-26 06:27","pubTimestamp":1714084061,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期科拓生物发布2024年一季报。根据财报显示，本报告期中科拓生物净利润减7.66%，盈利能力上升。截至本报告期末，公司营业总收入5902.56万元，同比下降18.19%，归母净利润1851.64万元，同比下降7.66%。公司最新一期年度报表的现金流为正，经营性现金流和利润相匹配。重仓科拓生物的前十大基金见下表：持有科拓生物最多的基金为鹏华新兴产业混合，目前规模为28.61亿元，最新净值2.482，较上一交易日下跌0.52%，近一年下跌18.84%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600013949.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858"],"gpt_icon":0},{"id":"2430476964","title":"科拓生物(300858)3月31日股东户数0.96万户，较上期增加1.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430476964","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430476964?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:19","pubTimestamp":1714036763,"startTime":"0","endTime":"0","summary":"证券之星消息，近日科拓生物披露，截至2024年3月31日公司股东户数为9560.0户，较12月31日增加165.0户，增幅为1.76%。在化学制品行业个股中，科拓生物股东户数低于行业平均水平，截至3月31日，化学制品行业平均股东户数为2.43万户。从股价来看，2023年12月31日至2024年3月31日，科拓生物区间跌幅为8.29%，在此期间股东户数增加165.0户，增幅为1.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500036131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858","BK0226"],"gpt_icon":0},{"id":"2430461997","title":"图解科拓生物一季报：第一季度单季净利润同比减7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430461997","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430461997?lang=zh_cn&edition=full","pubTime":"2024-04-25 01:38","pubTimestamp":1713980308,"startTime":"0","endTime":"0","summary":"证券之星消息，科拓生物2024年一季报显示，公司主营收入5902.56万元，同比下降18.19%；归母净利润1851.64万元，同比下降7.66%；扣非净利润1521.21万元，同比下降14.17%；负债率2.98%，投资收益28.02万元，财务费用-686.55万元，毛利率54.34%。财报数据概要请见下图: 以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500002314.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858"],"gpt_icon":0},{"id":"2429437702","title":"科拓生物最新公告：一季度净利润1851.6万元 同比下降7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429437702","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429437702?lang=zh_cn&edition=full","pubTime":"2024-04-24 20:10","pubTimestamp":1713960622,"startTime":"0","endTime":"0","summary":"科拓生物公布第一季度报告，营业收入5902.56万元，同比下降18.19%，净利润1851.6万元，同比下降7.66%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400042659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300858"],"gpt_icon":0},{"id":"2429988437","title":"4月24日科拓生物发布公告，其股东减持112.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2429988437","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429988437?lang=zh_cn&edition=full","pubTime":"2024-04-24 20:00","pubTimestamp":1713960052,"startTime":"0","endTime":"0","summary":"证券之星消息，4月24日科拓生物发布公告《科拓生物:关于股东减持计划期限届满的公告》，其股东张列兵于2023年8月24日至2024年4月24日间合计减持112.09万股，占公司目前总股本的0.4254%，变动期间该股股价下跌13.42%，截止4月24日收盘报15.1元。股东增减持详情见下表：根据科拓生物2023年三季报公布的十大股东详情如下：以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042400042231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300858"],"gpt_icon":0},{"id":"2429325964","title":"科拓生物(300858.SZ)发一季度业绩，净利润1851.6万元，同比减少7.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429325964","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429325964?lang=zh_cn&edition=full","pubTime":"2024-04-24 19:48","pubTimestamp":1713959299,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科拓生物(300858.SZ)发布2024年第一季度报告，营业收入5902.56万元，同比减少18.19%。归属于上市公司股东的净利润1851.6万元，同比减少7.66%。归属于上市公司股东的扣除非经常性损益的净利润1521.2万元，同比减少14.17%。基本每股收益0.07元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108965.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300858"],"gpt_icon":0},{"id":"2429432317","title":"科拓生物(300858.SZ)发2023年度业绩，净利润9347.99万元，同比减少14.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429432317","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429432317?lang=zh_cn&edition=full","pubTime":"2024-04-24 19:45","pubTimestamp":1713959126,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科拓生物(300858.SZ)发布2023年年度报告，营业收入2.99亿元，同比减少18.94%。归属于上市公司股东的净利润9347.99万元，同比减少14.93%。归属于上市公司股东的扣除非经常性损益的净利润8046万元，同比减少17.96%。基本每股收益0.35元，向全体股东每10股派发现金红利1.50元(含税)，送红股0股(含税)，以资本公积金向全体股东每10股转增0股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1108958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300858"],"gpt_icon":0},{"id":"2429316311","title":"东吴证券：给予科拓生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429316311","media":"证券之星","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2429316311?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:51","pubTimestamp":1713862299,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司孙瑜,周韵近期对科拓生物进行研究并发布了研究报告《国产替代进行时，益生菌第一股加速转型》，本报告对科拓生物给出买入评级，当前股价为14.59元。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300031343.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","300858"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-07-27","address":"北京市怀柔区雁栖经济开发区牤牛河路31号院1号-2","stockEarnings":[{"period":"1week","weight":-0.0118},{"period":"1month","weight":-0.0099},{"period":"3month","weight":-0.0754},{"period":"6month","weight":-0.1728},{"period":"1year","weight":-0.0819},{"period":"ytd","weight":-0.2551}],"companyName":"北京科拓恒通生物技术股份有限公司","boardCode":"AI0014","perCapita":"18722股","boardName":"食品制造业","registeredCapital":"26349万元","compareEarnings":[{"period":"1week","weight":-0.0304},{"period":"1month","weight":-0.0214},{"period":"3month","weight":-0.0654},{"period":"6month","weight":-0.0081},{"period":"1year","weight":-0.1043},{"period":"ytd","weight":-0.0296}],"survey":"　　北京科拓恒通生物技术股份有限公司的主营业务是从事复配食品添加剂、食用益生菌制品以及动植物微生态制剂研发、生产与销售。公司的主要产品分为食用益生菌原料菌粉、即食型复合益生菌固体饮料、发酵剂、生物保鲜剂等。公司是中关村高新技术企业，同时也是北京市“专精特新”中小企业、北京市知识产权试点单位。","serverTime":1721937991559,"listedPrice":23.7,"stockholders":"9560人(较上一季度增加1.76%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"科拓生物(300858)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供科拓生物(300858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"科拓生物,300858,科拓生物股票,科拓生物股票老虎,科拓生物股票老虎国际,科拓生物行情,科拓生物股票行情,科拓生物股价,科拓生物股市,科拓生物股票价格,科拓生物股票交易,科拓生物股票购买,科拓生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"科拓生物(300858)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供科拓生物(300858)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}